Market cap
$48 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-1 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-24.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.4
-
Face value
--
-
Shares outstanding
4,335,930
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Monterey Bio Acquisition Corp (MTRY)
| 6.1 | -1.4 | -0.5 | 9.1 | -- | -- | -- |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Monterey Bio Acquisition Corp (MTRY)
|
11.1 | 48.3 | 0.0 | -1.2 | -- | -6.1 | -- | 2.5 |
| 26.2 | 1,309.0 | 729.6 | 2.4 | 42.6 | 0.5 | 46.9 | 3.0 | |
| 16.5 | 123.8 | 0.0 | -23.8 | -- | -- | -- | 68.7 | |
| 10.4 | 260.8 | 0.0 | 4.4 | 12,898.1 | 2.3 | 57.9 | 1.3 | |
| 11.6 | 78.5 | 3.4 | -11.6 | -43.6 | -- | -- | 1.3 |
Shareholding Pattern
View DetailsAbout Monterey Bio Acquisition Corp (MTRY)
Monterey Innovation Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or related business combination with one or more... businesses in the biotech industry. The company was formerly known as Monterey Bio Acquisition Corporation and changed its name to Monterey Innovation Acquisition Corp. in March 2023. The company was incorporated in 2020 and is based in New York, New York. Read more
-
Chief Exec. Officer
Dr. Sanjeev Satyal Ph.D.
-
Chief Exec. Officer
Dr. Sanjeev Satyal Ph.D.
-
Headquarters
New York, NY
-
Website
FAQs for Monterey Bio Acquisition Corp (MTRY)
What is the current share price of Monterey Bio Acquisition Corp (MTRY) Today?
The share price of Monterey Bio Acquisition Corp (MTRY) is $11.14 (NASDAQ) as of 29-Nov-2023 09:30 EDT. Monterey Bio Acquisition Corp (MTRY) has given a return of 9.11% in the last 1 years.
What is the current PB & PE ratio of Monterey Bio Acquisition Corp (MTRY)?
Since, TTM earnings of Monterey Bio Acquisition Corp (MTRY) is negative, P/E ratio is not available.
The P/B ratio of Monterey Bio Acquisition Corp (MTRY) is 2.49 times as on 29-Nov-2023, a 27 discount to its peers’ median range of 3.39 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-24.73 |
1.60 |
2021 |
-50.87 |
0.25 |
2020 |
-- |
-- |
2022 |
-24.73 |
1.60 |
2021 |
-50.87 |
0.25 |
What is the 52 Week High and Low of Monterey Bio Acquisition Corp (MTRY)?
The 52-week high and low of Monterey Bio Acquisition Corp (MTRY) are Rs -- and Rs -- as of 01-Sep-2026.
What is the market cap of Monterey Bio Acquisition Corp (MTRY)?
Monterey Bio Acquisition Corp (MTRY) has a market capitalisation of $ 48 Mln as on 29-Nov-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Monterey Bio Acquisition Corp (MTRY)?
Before investing in Monterey Bio Acquisition Corp (MTRY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.